John Paulson

John Paulson

PAULSON & CO. INC.

CIK: 0001035674

Follow
Last Update On: Nov 01, 2025

Hedge fund manager recognized for his profitable short position against the subprime mortgage market in 2007, with a focus on merger arbitrage and distressed debt investing.

SEC Filings

# Form Name Filing Date
01
4 Changes in Beneficial Ownership 11/28/2025
02
13F-HR Institutional Holdings Report 11/14/2025
03
SCHEDULE 13D/A Amendment to Active Ownership Report 09/05/2025
04
N-PX N-PX 09/02/2025
05
SCHEDULE 13D/A Amendment to Active Ownership Report 08/14/2025
06
SCHEDULE 13D/A Amendment to Active Ownership Report 06/17/2025
07
SCHEDULE 13D/A Amendment to Active Ownership Report 06/16/2025
08
SCHEDULE 13D/A Amendment to Active Ownership Report 05/21/2025
09
13F-HR Institutional Holdings Report 05/15/2025
10
4 Changes in Beneficial Ownership 03/05/2025
11
SCHEDULE 13G/A Amendment to Passive Ownership Report 02/14/2025

Frequently Asked Questions

02

Hedge fund manager recognized for his profitable short position against the subprime mortgage market in 2007, with a focus on merger arbitrage and distressed debt investing.

02

Explore John Paulson largest investments on Stocks.News, including companies like Bausch Health Companies Inc. , Horizon Therapeutics Public Limited Company , Madrigal Pharmaceuticals, Inc. , and their significance in his portfolio.

02

John Paulson portfolio updates are typically published quarterly through SEC 13F filings, which provide detailed information about their holdings, including recent buys and sells.

02

John Paulson currently invests in companies such as Alphabet Inc.

02

The largest holding in John Paulson portfolio is Bausch Health Companies Inc..

02

As of Jun 30, 2025, John Paulson portfolio is valued at approximately $2.01 B, based on the latest filings available on Stocks.News.